MedTrace Logo

Ultrasound, Doppler ,and Calprotectin in Necrotizing Enterocolitis Diagnosis

NCT03257553 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2018-01-23

No results posted yet for this study

Summary

Necrotizing enterocolitis continues to be a disease that is associated with significant morbidity and mortality in premature infants due to advances in neonatal intensive care that increase the survival rate of extremely low birth weight infants (below 1,000 gram)

Conditions

  • Necrotizing Enterocolitis

Interventions

DIAGNOSTIC_TEST

fecal calprotectin , doppler and ultrasound

faecal sample for measurement of calprotectin level ultrasound and doppler

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Azhar Arabi, MD · Assiut University

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Day
Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-30
Primary Completion
2018-10-31
Completion
2019-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03257553 on ClinicalTrials.gov